Robust measurement of clinical improvement in patients with cutaneous lupus erythematosus
Objective The severity and disease course of cutaneous lupus erythematosus (CLE) are highly variable. Consequently, outcome measures for CLE clinical improvement are heterogeneous, complicating treatment decisions and therapeutic development. This study characterises CLE outcome measures and identif...
Saved in:
| Main Authors: | Benjamin A Nanes, Jane L Zhu, Benjamin F Chong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-10-01
|
| Series: | Lupus Science and Medicine |
| Online Access: | https://lupus.bmj.com/content/7/1/e000364.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acute Cutaneous Lupus Erythematosus
by: K. C. Manish, et al.
Published: (2021-10-01) -
Successful treatment of recalcitrant cutaneous lupus erythematosus with anifrolumab in patients without systemic lupus erythematosus
by: Bishoy Abdelmalik, BS, et al.
Published: (2025-01-01) -
Isoniazid - induced chronic cutaneous Lupus erythematosus
by: A Chiriac, et al.
Published: (2016-01-01) -
Isoniazid - induced chronic cutaneous Lupus erythematosus
by: A Chiriac, et al.
Published: (2016-01-01) -
Successful use of anifrolumab in refractory cutaneous lupus erythematosus with systemic lupus erythematosus: A case report
by: Abdullah Ramadhan, et al.
Published: (2025-06-01)